Pilocarpine — Membership Pricing
Pilocarpine is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.
Pilocarpine Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Membership pricing may be available |
| Typical Retail | $172.00 |
Membership pricing may be available; confirm the price with the dispensing pharmacy.
About Pilocarpine
Pilocarpine is a prescription medication. Ask your doctor if Pilocarpine is right for you.
Other strengths and forms of Pilocarpine
How to Check Pilocarpine Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Pilocarpine at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Ophthalmology
What Pilocarpine is approved for (FDA label)
Pilocarpine hydrochloride tablets are indicated for: The treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck. The treatment of symptoms of dry mouth in patients with Sjogren’s Syndrome.
Source: Read the full FDA label on DailyMed. Label effective date: April 15, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Pilocarpine (FDA label)
Head & Neck Cancer Patients In controlled studies, 217 patients received pilocarpine, of whom 68% were men and 32% were women. Race distribution was 91% Caucasian, 8% Black, and 1% of other origin. Mean age was approximately 58 years. The majority of patients were between 50 and 64 years (51%), 33% were 65 years and older and 16% were younger than 50 years of age. The most frequent adverse experiences associated with pilocarpine hydrochloride tablets were a consequence of the expected pharmacologic effects of pilocarpine.
Source: FDA prescribing information (DailyMed). Set ID: 6272ccac-b543-404d-9938-8583bb59ed2c. SPL document ID: 83bbaf17-9d8e-494a-8e76-361550296b5e. Label effective date: April 15, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Pilocarpine (FDA label)
Pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.
Source: FDA prescribing information (DailyMed). Set ID: 6272ccac-b543-404d-9938-8583bb59ed2c. SPL document ID: 83bbaf17-9d8e-494a-8e76-361550296b5e. Label effective date: April 15, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Pilocarpine (FDA label)
Pilocarpine should be administered with caution to patients taking beta-adrenergic antagonists because of the possibility of conduction disturbances. Drugs with parasympathomimetic effects administered concurrently with pilocarpine would be expected to result in additive pharmacologic effects. Pilocarpine might antagonize the anticholinergic effects of drugs used concomitantly. These effects should be considered when anticholinergic properties may be contributing to the therapeutic effect of concomitant medication (e.g., atropine, inhaled ipratropium). While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren’s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.
Source: FDA prescribing information (DailyMed). Set ID: 6272ccac-b543-404d-9938-8583bb59ed2c. SPL document ID: 83bbaf17-9d8e-494a-8e76-361550296b5e. Label effective date: April 15, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.